Mast cell production of interleukin-10 (IL-10) can limit the skin pathology induced by chronic low-dose ultraviolet (UV)-B irradiation. Although the mechanism that promotes mast cell IL-10 production in this setting is unknown, exposure of the skin to UVB irradiation induces increased production of the immune modifying agent 1,25-dihydroxyvitamin D₃ (1,25[OH]₂D₃). We now show that 1,25(OH)₂D₃ can up-regulate IL-10 mRNA expression and induce IL-10 secretion in mouse mast cells in vitro. To investigate the roles of 1,25(OH)₂D₃ and mast cell vitamin D receptor (VDR) expression in chronically UVB-irradiated skin in vivo, we engrafted the skin of genetically mast cell–deficient WBB6F₁-Kit^W/W-v mice with bone marrow–derived cultured mast cells derived from C57BL/6 wild-type or VDR^–/– mice. Optimal mast cell–dependent suppression of the inflammation, local production of proinflammatory cytokines, epidermal hyperplasia, and epidermal ulceration associated with chronic UVB irradiation of the skin in Kit^W/W-v mice required expression of VDR by the adoptively transferred mast cells. Our findings suggest that 1,25(OH)₂D₃/VDR-dependent induction of IL-10 production by cutaneous mast cells can contribute to the mast cell’s ability to suppress inflammation and skin pathology at sites of chronic UVB irradiation.